These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1567 related items for PubMed ID: 18653221

  • 1. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 2. AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.
    Schwarz TF.
    Expert Rev Vaccines; 2008 Dec; 7(10):1465-73. PubMed ID: 19053203
    [Abstract] [Full Text] [Related]

  • 3. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.
    Schwarz TF.
    Adv Ther; 2009 Nov; 26(11):983-98. PubMed ID: 20024678
    [Abstract] [Full Text] [Related]

  • 4. Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.
    David MP, Van Herck K, Hardt K, Tibaldi F, Dubin G, Descamps D, Van Damme P.
    Gynecol Oncol; 2009 Dec; 115(3 Suppl):S1-6. PubMed ID: 19217149
    [Abstract] [Full Text] [Related]

  • 5. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P, Henrion R, Blanc B, Girard M, Sancho-Garnier H.
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [Abstract] [Full Text] [Related]

  • 6. Prospects for cervical cancer prevention by human papillomavirus vaccination.
    Schiller JT, Lowy DR.
    Cancer Res; 2006 Nov 01; 66(21):10229-32. PubMed ID: 17079437
    [Abstract] [Full Text] [Related]

  • 7. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I.
    Klin Mikrobiol Infekc Lek; 2006 Jun 01; 12(3):91-7. PubMed ID: 17051469
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP.
    PLoS Med; 2006 May 01; 3(5):e138. PubMed ID: 16573364
    [Abstract] [Full Text] [Related]

  • 9. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M, Dillner J.
    J Clin Virol; 2007 Mar 01; 38(3):189-97. PubMed ID: 17258503
    [Abstract] [Full Text] [Related]

  • 10. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
    Society of Gynecologic Oncologists Education Resource Panel Writing groupUniversity of Illinois, Chicago, IL, USA., Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, Rader JS, Wright J.
    Gynecol Oncol; 2006 Sep 01; 102(3):552-62. PubMed ID: 16979432
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S, Alain S, Denis F.
    Gynecol Obstet Fertil; 2006 Sep 01; 34(7-8):647-55. PubMed ID: 16807045
    [Abstract] [Full Text] [Related]

  • 13. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.
    Med Klin (Munich); 2007 Jul 15; 102(7):515-23. PubMed ID: 17634869
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types.
    Szarewski A.
    Expert Rev Vaccines; 2012 Jun 15; 11(6):645-57. PubMed ID: 22873123
    [Abstract] [Full Text] [Related]

  • 17. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J.
    Gynecol Obstet Fertil; 2006 Mar 15; 34(3):189-201. PubMed ID: 16529969
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus vaccine for genotypes 6, 11, 16 and 18: new drug. Cervical cancer prevention: high hopes...
    Prescrire Int; 2007 Jun 15; 16(89):91-4. PubMed ID: 17582921
    [Abstract] [Full Text] [Related]

  • 19. Correlating immunity with protection for HPV infection.
    Frazer I.
    Int J Infect Dis; 2007 Nov 15; 11 Suppl 2():S10-6. PubMed ID: 18162240
    [Abstract] [Full Text] [Related]

  • 20. Prevention of cervical cancer: where immunology meets diagnostics.
    Meijer CJ, Heideman DA, Berkhof H, Snijders PJ.
    Immunol Lett; 2009 Feb 21; 122(2):126-7. PubMed ID: 19100775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.